|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In-Depth Reviews |
Department of Internal Medicine, University of Virginia Health System, Charlottesville, Virginia
1 To whom correspondence should be addressed. E-mail: mhr9r{at}virginia.edu.
| Abstract |
|---|
Acute renal failure (ARF) occurs in up to 30% of patients who undergo cardiac surgery, with dialysis being required in approximately 1% of all patients. The development of ARF is associated with substantial morbidity and mortality independent of all other factors. The pathogenesis of ARF involves multiple pathways. Hemodynamic, inflammatory, and nephrotoxic factors are involved and overlap each other in leading to kidney injury. Clinical studies have identified risk factors for ARF that can be used to determine effectively the risk for ARF in patients who undergo bypass surgery. These high-risk patients then can be targeted for renal protective strategies. Thus far, no single strategy has demonstrated conclusively its ability to prevent renal injury after bypass surgery. Several compounds such as atrial natriuretic peptide and N-acetylcysteine have shown promise, but large-scale trials are needed.
This article has been cited by other articles:
![]() |
S. U. Nigwekar and P. Kandula N-Acetylcysteine in Cardiovascular-Surgery-Associated Renal Failure: A Meta-Analysis Ann. Thorac. Surg., January 1, 2009; 87(1): 139 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Naughton, D. Wijeysundera, K. Karkouti, G. Tait, and W. S. Beattie N-acetylcysteine to reduce renal failure after cardiac surgery: a systematic review and meta-analysis: [Etude methodique et meta-analyse : la N-acetylcysteine dans la reduction de l'insuffisance renale a la suite d'une chirurgie cardiaque] Can J Anesth, December 1, 2008; 55(12): 827 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Knapik, P. Rozentryt, P. Nadziakiewicz, L. Polonski, and M. Zembala Retrospective cross-validation of simplified predictive index for renal replacement therapy after cardiac surgery Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 1101 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rosenberger, S. Rosen, A. Shina, U. Frei, K.-U. Eckardt, L. A. Flippin, M. Arend, S. J. Klaus, and S. N. Heyman Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3472 - 3478. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Gammie, L. S. Krowsoski, J. M. Brown, P. N. Odonkor, C. A. Young, M. J. Santos, J. S. Gottdiener, and B. P. Griffith Aortic Valve Bypass Surgery: Midterm Clinical Outcomes in a High-Risk Aortic Stenosis Population Circulation, September 30, 2008; 118(14): 1460 - 1466. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Massoudy, S. Wagner, M. Thielmann, U. Herold, E. Kottenberg-Assenmacher, G. Marggraf, A. Kribben, T. Philipp, H. Jakob, and S. Herget-Rosenthal Coronary artery bypass surgery and acute kidney injury--impact of the off-pump technique Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2853 - 2860. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Candela-Toha, E. Elias-Martin, V. Abraira, M. T. Tenorio, D. Parise, A. de Pablo, T. Centella, and F. Liano Predicting Acute Renal Failure after Cardiac Surgery: External Validation of Two New Clinical Scores Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1260 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Arora, S. Rajagopalam, R. Ranjan, H. Kolli, M. Singh, R. Venuto, and J. Lohr Preoperative Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Is Associated with Increased Risk for Acute Kidney Injury after Cardiovascular Surgery Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1266 - 1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Himmelfarb, M. Joannidis, B. Molitoris, M. Schietz, M. D. Okusa, D. Warnock, F. Laghi, S. L. Goldstein, R. Prielipp, C. R. Parikh, et al. Evaluation and Initial Management of Acute Kidney Injury Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 962 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bennett, C. L. Dent, Q. Ma, S. Dastrala, F. Grenier, R. Workman, H. Syed, S. Ali, J. Barasch, and P. Devarajan Urine NGAL Predicts Severity of Acute Kidney Injury After Cardiac Surgery: A Prospective Study Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 665 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Wijeysundera, W. S. Beattie, V. Rao, J. T. Granton, and C. T. Chan N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency: [Recours a la N-acetylcysteine pour prevenir une atteinte renale aigue chez les patients de chirurgie cardiaque souffrant d'une insuffisance renale moderee preexistante] Can J Anesth, November 1, 2007; 54(11): 872 - 881. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |